Neuronetics (STIM) Current Deferred Revenue (2017 - 2025)
Neuronetics (STIM) has disclosed Current Deferred Revenue for 9 consecutive years, with $754000.0 as the latest value for Q3 2025.
- On a quarterly basis, Current Deferred Revenue fell 42.49% to $754000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $754000.0, a 42.49% decrease, with the full-year FY2024 number at $974000.0, down 39.88% from a year prior.
- Current Deferred Revenue was $754000.0 for Q3 2025 at Neuronetics, down from $894000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $2.5 million in Q4 2021 to a low of $754000.0 in Q3 2025.
- A 5-year average of $1.6 million and a median of $1.7 million in 2023 define the central range for Current Deferred Revenue.
- Peak YoY movement for Current Deferred Revenue: increased 23.81% in 2021, then crashed 51.63% in 2025.
- Neuronetics' Current Deferred Revenue stood at $2.5 million in 2021, then dropped by 20.83% to $2.0 million in 2022, then dropped by 18.18% to $1.6 million in 2023, then tumbled by 39.88% to $974000.0 in 2024, then dropped by 22.59% to $754000.0 in 2025.
- Per Business Quant, the three most recent readings for STIM's Current Deferred Revenue are $754000.0 (Q3 2025), $894000.0 (Q2 2025), and $785000.0 (Q1 2025).